Here’s what we’ll discuss:
Artificial Intelligence (AI) is rapidly transforming the life sciences and pharmaceutical industries, offering exciting innovations and improvements. Here’s what you can look forward to with AI in Life sciences:
- Faster Drug Discovery: AI accelerates the identification and development of new drugs by analysing vast datasets from generic research, clinical trials, and medical records.
- Improved Clinical Trials: AI enhances the efficiency and effectiveness of clinical trials by identifying the right candidate faster, providing real-time data analysis to ensure safety and compliance, and anticipating outcomes and potential issues.
- Personalized Medicine: AI enables the creation of personalised treatment plans by analysing individual genetic information and medical histories.
- Optimised Supply Chain and Manufacturing: AI optimises every aspect of the supply chain, from production scheduling to inventory management, ensuring the timely delivery of high-quality products while reducing costs and waste.
- Enhanced Data Integration: AI facilitates the integration of data across different systems and platforms, creating comprehensive patient profiles and enabling seamless information exchange.
- Regulatory Compliance: AI automates compliance reporting, ensuring adherence to regulations and reducing the administrative burden on life sciences companies.
The Future is Here with Infosys Life Sciences
The integration of AI in the life sciences and pharmaceutical industries promises a future where innovation is faster, treatments are more effective, and patient care is personalized. Infosys Life Sciences is leading the change in harnessing the potential of AI to revolutionize pharmaceuticals and improve lives.
Infosys is pleased to host and invite you to a networking entertainment dinner with leaders and peers from the Life Sciences industry on “AI in Life Sciences” in November 2024 in London. Join us to explore how AI-driven transformation can harness the power of data for operational efficiency in pharma.
AGENDA
17:30 onwards
Registration
18:00 – 18:30
Gallery Viewing Experience
18:30 – 19:00
Journal Launch Celebration
19:00 – 19:20
Welcome Keynote
19:20 – 19:40
Keynote Session
19:40 – 20:10
Keynote by Guest Speaker
20:10 – 20:30
Panel Discussion
Vice President & Portfolio Head Europe Life sciences(UK&I, France , Benelux and Israel), Infosys
20:30 onwards
Networking Dinner
This is an executive peer group meeting for 10-12 senior leaders. We use a conversational, story-telling approach that works best when everyone participates.
Dinner at The Shard, London
The Shard,
32 London Bridge St, London SE1 9SG, United Kingdom
View on map
Participation in this in-person networking session is at no cost to qualified attendees. Once you’ve completed the registration, we’ll confirm your invitation and send you a calendar invite with directions to the venue.